Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|April 27, 2025
A review of pharmacokinetic data describing long-acting injectable cabotegravir during pregnancyShawnalyn W Sunagawa, Kimberly K Scarsi
Antimicrobial Agents and Chemotherapy|February 2, 2021
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure ProphylaxisSubhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, et al.
Open Forum Infectious Diseases|July 31, 2026
Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIVEmily Dyer, Shawnalyn W Sunagawa, Nichole Regan, et al.
ACG Case Reports Journal|January 5, 2023
Turmeric-Associated Drug-Induced Liver InjuryShawnalyn W Sunagawa, Conor Houlihan, Brandon Reynolds, et al.
Nanomaterials (Basel, Switzerland)|June 10, 2022
Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept StudySubhra Mandal, Shawnalyn W Sunagawa, Pavan Kumar Prathipati, et al.
Open Forum Infectious Diseases|February 18, 2025
Utilization of Doxycycline Postexposure Prophylaxis at a Midwestern United States HIV/PrEP ClinicShawnalyn W Sunagawa, Gabriel Codling, Elizabeth Lyden, et al.
Open Forum Infectious Diseases|December 25, 2023
Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case ReportShawnalyn W Sunagawa, Joshua P Havens, Anthony Podany, et al.
Open Forum Infectious Diseases|March 16, 2026
Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment ProgramJoshua P Havens, Jennifer O'Neill, Maureen Kubat, et al.
Open Forum Infectious Diseases|May 20, 2026
Engagement in Care and Sexually Transmitted Infection Screening Among Patients Prescribed Doxycycline Postexposure Prophylaxis at a Midwestern HIV/Preexposure Prophylaxis ClinicVanessa Lo, Kathleen Nguyen, Sydney Bernhard, et al.
Pharmacotherapy|June 11, 2026
Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?Jonathan H Ryder, Shawnalyn W Sunagawa, Nathaniel J Rhodes, et al.
Pageof 2